Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Basic Tests for Pharmaceutical Substances
(1986; 216 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentWorld Health Organization Publications Relating to Quality Assurance of Pharmaceutical Products
View the document1. Introduction
View the document2. Determination of melting characteristics
View the document3. Tests
View the document4. Equipment
View the document5. Reagents
View the documentAcknowledgements
View the documentWHO Publications
View the documentBack cover


Acknowledgements are due to the following members of the WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations and other specialists who have collaborated in establishing and verifying the procedures described in this volume: Dr E. O. P. Agbakwuru, Department of Pharmaceutical Chemistry and Pharmacognosy, University of Benin, Benin City, Nigeria; Professor A. H. Beckett, Department of Pharmacy, Chelsea College of Science and Technology, University of London, London, England; Mr J. Y. Binka, Quality Control Unit, Ministry of Health, Accra, Ghana; Dr H. R. Bolliger, Hoffmann-La Roche & Co. AG, Basle, Switzerland; Mr Chen Chang-lin, Chinese Pharmacopoeia Commission, Ministry of Health, Beijing, China; Dr B. Clement, Institute for Pharmaceutical Chemistry, University of Freiburg, Federal Republic of Germany; Dr M. El Fekih, Ministry of Health, Tunis, Tunisia; Dr K. Florey, Analytical Research and Development, The Squibb Institute for Medical Research, New Brunswick, NJ, USA; Dr I. Haq, Drugs Control and Research Division, Government of Pakistan, National Health Laboratories, Islamabad, Pakistan; Professor K. Hartke, Institute for Pharmaceutical Chemistry, University of Marburg, Marburg/Lahn, Federal Republic of Germany; Dr A. Häussler, Pharmaceutical Quality Control, Hoechst AG, Frankfurt am Main, Federal Republic of Germany; Professor A. W. M. Indemans, Laboratory of the Dutch Pharmaceutical Society, The Hague, Netherlands; Professor P. Ionesco-Stoian, Academy of Medical Sciences, Bucharest, Romania; Mr C. A. Johnson, British Pharmacopoeia Commission, London, England; Dr C. S. Kumkumian, Office of New Drug Evaluation, Food and Drug Administration, Rockville, MD, USA; Dr W. Kwapiszewski, Department of Pharmaceutical Chemistry, Medical Academy, Warsaw, Poland; Professor J. Laszlovszky, National Institute of Pharmacy, Budapest, Hungary; Dr K. Lingner, Ciba-Geigy AG, Basle, Switzerland; Dr A. J. Listen, Drugs Directorate, Ottawa, Ontario, Canada; Professor G. B. Marini Bettólo, Institute of Chemistry, Sacred Heart Catholic University, Rome, Italy; Dr N. Muraguri, Government Chemist's Department, Nairobi, Kenya; Dr E. Nieminen, National Control Laboratory for Medicines, Helsinki, Finland; Dr P. R. Pabrai, Central Indian Pharmacopoeia Laboratory, Ghaziabad, India; Dr M. Pesez, Roussel-Uclaf SA, Romainville, France; Professor J. Richter, Institute of Pharmacology and Therapeutics of the German Democratic Republic, Berlin, German Democratic Republic; Dr N. Rofael, Pharmaceutical Control and Research Laboratories, National Organization for Drug Control and Research, Cairo, Egypt; Dr S. K. Roy, Central Drugs Laboratory, Calcutta, India; Professor R. B. Salama, Faculty of Pharmacy, University of Khartoum, Sudan; Mr R. J. Samsom, Health Protection Branch, Ministry of Public Health and the Environment, Leidschendam, Netherlands; Dr E. Schlederer, State Institute for Chemical and Pharmaceutical Analysis, Vienna, Austria; Dr P. J. Schorn, European Pharmacopoeia Commission, Council of Europe, Strasbourg, France; Dr G. Schwartzman, The Association of Official Analytical Chemists, Arlington, VA, USA; Dr S. C. Sharma, Central Indian Pharmacopoeia Laboratory, Ghaziabad, India; Professor S. Sokolov, Department of New Drugs and Medical Equipment, Ministry of Health, Moscow, USSR; Professor Tu Guoshi, Division of Pharmaceutical Chemistry, National Institution for the Control of Pharmaceutical and Biological Products, Ministry of Health, Beijing, China; Miss J. Verdier, Roussel-Uclaf SA, Romainville, France; Dr W. Wieniawski, Institute of Drug Research and Control, Warsaw, Poland; Dr B. A. Wills, Department of Health and Social Security, London, England; Mr Yeap Boon Chye, Pharmacy Division, Ministry of Health, Kuala Lumpur, Malaysia; Professor Yuan Shi-chen, Chinese Pharmacopoeia Commission, Ministry of Health, Beijing, China.

Particular appreciation is accorded to Dr M. Pesez, Roussel-Uclaf SA, Romainville, France, for undertaking accelerated stability testing on the large majority of substances listed.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017